The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
In the world of obesity research, the arrival of GLP-1 drugs like Ozempic feels seismic. At a recent conference, Martin Binks, a leader in obesity research, found himself marveling with a colleague: ...
Doctors, patients and researchers are at the very beginning of understanding how the new weight loss medicines interact with eating disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results